Navigation Links
Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics

SAN DIEGO, Jan. 6 /PRNewswire/ -- Accumetrics, Inc. has appointed Andrew Chisholm to the position of Vice President, Sales and Corporate Accounts.

"Andrew brings the right mix of energy and expertise to Accumetrics. His experience will help us reach the next level in terms of our market penetration," says Timothy I. Still, President and CEO at Accumetrics. "His knowledge of the medical diagnostics industry and his relationships with distributors make him a key component of our growth strategy in 2009 and beyond."

Prior to joining Accumetrics, Mr. Chisholm served as Vice President of Sales and Corporate Accounts at Hemosense, a medical diagnostics company located in San Jose, California which was acquired by Inverness Medical in November 2007. Prior to that, Mr. Chisholm managed sales and marketing activities with increasing responsibilities at Bayer Healthcare, Henry Schein, Johnson & Johnson and the Eastman Kodak Company.

About Accumetrics (

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

    CONTACT:  Jules Abraham
              Lippert Heilshorn & Associates

              Timothy I. Still

SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Algeta Appoints Andrew Kay as President and Chief Executive Officer
2. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
3. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
4. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
5. MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
6. Vical Names Andrew de Guttadauro Vice President, Corporate Development
7. Timothy I. Still Appointed CEO at Accumetrics
8. Robert Cantu Appointed Vice President of Pierpoint International
9. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
10. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
11. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
Post Your Comments:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
Breaking Biology News(10 mins):